Devices, deals, Stents

BSX Buys Irish Stent Firm

Ryan McBride 1/6/09

Boston Scientific (NYSE:BSX), the Natick, MA-based medical devices giant, reports that it has acquired drug-eluting stent developer Labcoat, headquartered in Galway, Ireland. Labcoat has developed technology to produce ultra-thin coatings of biodegradable polymers and drugs on the outer surface of coronary stents, which are designed to prop open arteries after surgeries to remove plaques. Financial terms of the deal weren’t disclosed.

Ryan McBride is Xconomy's correspondent. You can reach him at rmcbride@xconomy.com.